Skip to content
Movie Casting Call
Author:
JJP Biologics
JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)
June 3, 2026